Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate for smooth extubation
NCT04617652Phase 4Completed
- Sponsor
- Fayoum University Hospital
- Start
- Aug 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of magnesium sulfate in Emergence agitation (EA), sponsored by Fayoum University Hospital. Primary endpoint: Smoothness of extubation. Started Aug 2020; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT04617652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04617652.